Closing the breast cancer gap for Black women
Are 3D mammograms better than standard 2D imaging for catching advanced cancers?
Stay updated with breaking news from Advanced Cancers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Are 3D mammograms better than standard 2D imaging for catching advanced cancers?
Previously announced agreement for F-star Therapeutics to be acquired by invoX Pharma; transaction expected to close in the second half of 2022 License Agreement with Takeda to Develop and... | August 11, 2022
On-track to activate first US clinical trial sites in on-going pivotal phase III global registration study, NANORAY-312, in locally advanced head and neck squamous cell carcinoma (LA-HNSCC) in Q3
On-track to activate first US clinical trial sites in on-going pivotal phase III global registration study, NANORAY-312, in locally advanced head and neck squamous cell carcinoma (LA-HNSCC) in Q3
18.05.2022 - Regulatory News: NANOBIOTIX (Euronext: NANO - NASDAQ: NBTX - the 'Company'), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today announced operational ... Seite 1